Bridge Project collaborators David Weinstock (left, Dana-Farber Cancer Institute), Scott Manalis (center, MIT), and visiting scientist Mark Stevens (right, MIT), demonstrated clinical application of the Manalis Lab’s cell-weighing technology for predicting individual patient response to cancer therapies.
Bridge Project funding must be acknowledged in publications, presentations, and invention disclosures. Please email ki-bridge@mit.edu when submitting a manuscript, when manuscripts are accepted, or when filing an invention disclosure.
Example acknowledgement text
Supported by the Bridge Project, a partnership between the Koch Institute for Integrative Cancer Research at MIT and the Dana-Farber/Harvard Cancer Center
